Keros Therapeutics, Inc.

NASDAQ:KROS

16.42 (USD) • At close December 27, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Operating Activities:
Net Income -52.956-45.257-43.114-40.243-39.44-37.505-35.804-29.718-23.509-27.266-24.186-6.94-20.297-15.622-15.885-10.676-12.036-10.757-11.892-2.751-3.549-2.853-3.183
Depreciation & Amortization 0.3140.3060.2770.2470.210.1910.1670.1270.1260.3080.1130.1040.1030.0910.080.0750.0720.0680.0630.0590.0550.0490.045
Deferred Income Tax 000000000000.02600.02000000000
Stock Based Compensation 8.8178.7858.077.3248.7117.0415.6874.7464.7544.7944.3883.2953.0842.8492.4941.5221.4241.1390.0120.0180.0170.0130.011
Change In Working Capital 14.113-3.981-10.1326.878-3.804-0.913-4.8113.08-6.195-0.63218.055-16.9573.258-5.0782.7070.99-0.365-0.4682.118-3.691-0.068-2.926-0.039
Accounts Receivables -0.3840.222-0.083-0.14300000018-180.1-0.1000000000
Change In Inventory 0005.84800000001800000000000
Change In Accounts Payables -1.5921.6130.0231.044-0.182-0.571.3220.595-4.9944.659-0.6680.8231.439-1.6360.8590.433-3.1362.957-0.193-0.130.846-0.2170.813
Other Working Capital 16.089-5.816-10.0720.129-3.622-0.343-6.1332.485-1.201-5.2910.723-17.781.819-3.4421.8480.5572.771-3.4252.311-3.561-0.914-2.709-0.852
Other Non Cash Items -0.7887.9089.0230.3350.3410.3540.5260.3220.2220.2060.2030.907-0.5890.1030.0990.0980.0490.0911.5790.8670.590.6850.653
Operating Cash Flow -30.5-39.801-44.56-25.459-33.982-30.832-34.235-21.443-24.602-22.59-1.427-19.565-14.441-17.637-10.505-7.991-10.856-9.927-8.12-5.498-2.955-5.032-2.513
Investing Activities:
Investments In Property Plant And Equipment -0.386-0.31-0.946-0.541-0.55-0.311-1.062-0.351-0.176-0.567-0.147-0.159-0.145-0.51-0.21-0.06-0.03-0.028-0.176-0.018-0.082-0.1710
Acquisitions Net 00000000000000000000000
Purchases Of Investments 00000000000000000000000
Sales Maturities Of Investments 00000000000000000000000
Other Investing Activites 00000000000000000000000
Investing Cash Flow -0.386-0.31-0.946-0.541-0.55-0.311-1.062-0.351-0.176-0.567-0.147-0.159-0.145-0.51-0.21-0.06-0.03-0.028-0.176-0.018-0.082-0.1710
Financing Activities:
Debt Repayment 00000000000000000000000
Common Stock Issued 155.0660.629151.3468.5170.2841.74107.30861.40148.4879.690.11828.1710.0350.0570.042140.5300560000
Common Stock Repurchased 00000000000000000000000
Dividends Paid 00000000000000000000000
Other Financing Activities 0.8782.9025.4620.7370.2841.740.370.0150.0960.5020.1180.2450.0350.0570.042-0.4130.009100.12455.7940.0040.0060.0040
Financing Cash Flow 155.9443.531156.80269.2540.2841.74107.67861.41648.58310.1920.11828.4160.0350.0570.042140.1170.009100.12455.7940.0040.0060.0040
Other Information:
Effect Of Forex Changes On Cash 000046.693000000000000000000
Net Change In Cash 125.058-36.58111.29643.254-34.248-29.40372.38139.62223.805-12.965-1.4568.692-14.551-18.09-10.673132.066-10.87790.16947.498-5.512-3.031-5.199-2.513
Cash At End Of Period 532.133405.863442.443332.359289.105323.353352.756280.375240.753216.948229.913231.369222.677237.228255.318265.991133.925144.80254.6337.13512.64715.67820.877